top of page

Our History

In the fast-growing metroplex of Phoenix, Arizona, we formed Calviri in 2017 to end cancer. This was made feasible by our discovery of an unappreciated, yet fundamental, molecular characteristic of all tumors that distinguishes them from healthy host cells. To leverage this discovery, we invented technologies that merge biology with semiconductor chips.

 

These research and development efforts provided the means for diagnostics and vaccines that are unlike any others. Today, we are focused on commercializing our canine multi-cancer tests that accurately detect stage 1 disease, and our multi-cancer, early-stage therapeutic vaccines to treat it. Next, our product line will include vaccines to prevent cancers from starting. We are determined to provide diagnostics and vaccines for our pets worldwide.

Company Timeline

2017

2018

2019

2020

2021

2022

2023

2024

Company launches

​

Round 1 investor funding, $2.25MM

​

Stephen Johnston inducted into the National Academy of Inventors

Company obtains exclusive license to Johnston patents from ASU

​​​​

Open Philanthropy grant is funded, $6.4MM

Company initiates VACCS Trial

Independent Safety Board reports no adverse events in trial

​

New Board of Directors is formed

​

Round 2 investor funding, $5MM

Lab and production teams move to new sites in Phoenix and Tempe​

​

Company awarded Most Fundable Company title​

Scientific Advisory Board is formed​

​

VACCS trial enrollment of 800+ dogs completed

​

Round 3 investor funding, $11.3MM

Company moves to new Phoenix lab​

​

Open house celebration for new lab​

​

Company’s first scientific publication

​

Company’s first VACCS clinical trial publication

VACCS trial completed â€‹â€‹

​

Company earns Arizona Bioscience Company of the Year Award 

​

Hemangiosarcoma (HSA) trial initiated

Our Board of Directors

Integrity. Responsibility. Dedication. 

Our Board of Directors is a team of successful leaders with diverse expertise, talents and backgrounds, yet all focused on equipping the company with the leadership tools to end cancer. 

Le Benger MD, Jeffrey (BOD)-Headshot 2023.jpg

Jeffrey Le Benger, MD, FACS

Chairman

Sokolov, Jacque (BOD)-Headshot 2022 (Plain Background).jpg

Jacque Sokolov, MD

Director

McCallister, Michael-Headshot (Director).jpg

Michael McAllister

Director

Johnston, Stephen-Desert.png

Stephen Albert Johnston

Director, CEO and Co-Founder

mug.jpg

Kathryn Sykes, PhD

Director, VP Research & Product Development, Co-Founder

Calviri At A Glance:

Diagnostic Pipeline

  • Canine multi-cancer stage 1 detection test â€‹â€‹

Vaccine Pipeline

  • Canine preventative cancer vaccine  

​

  • Canine stage 1 hemangiosarcoma (HSA) therapeutic vaccine 

​

  • Canine multi-cancer therapeutic vaccine 

Canine Trials

  • VACCS preventative vaccine trial completed 

​

  • HSA therapeutic vaccine trial underway â€‹

Our Scientific Advisory Board

Expertise. Commitment. Motivation. 

Our Scientific Advisory Board is a team of intellectually rich scientists that steer Calviri’s innovations into world changing products. 

McInnis, Terry (SAB)-Headshot 2023 (Beige Background)_edited.jpg

Terry A. McInnis, MD, MBA, MPH

Chairman

Lapidus, Stan (SAB)-Headshot 2023 (Bow Tie Hi Res for Cropped-Website).JPG

Stan Lapidus

Scientific Advisor

Ballantyne, John Headshot (SAB)_edited.jpg

John Ballantyne, PhD

Scientific Advisor

Lee MD, Peter P. (SAB)-Headshot 2023.jpg

Peter P. Lee MD

Scientific Advisor

Johnston, Stephen-Desert.png

Stephen Albert Johnston

Director, CEO and Co-Founder

mug.jpg

Kathryn Sykes, PhD

Director, VP Research & Product Development, Co-Founder

Dow, Steven Headshot (SAB).jpeg

Steven W. Dow, DVM, PhD

Scientific Advisor

Partners

Week of May 13th Graphic 1 (3)_edited.jp
Week of May 13th Graphic 1 (2)_edited.jp
Week of May 13th Graphic 1 (5)_edited.jp
Week of May 13th Graphic 1 (4)_edited.jp
Week of May 13th Graphic 1_edited.jpg
flint.png

Contact Us

Please direct any questions or comments you have for us via our contact form below.

Wexford-50-phoenix-Project-Hero-Image-PBC-1.jpg

850 N. 5th Street Phoenix, AZ

Thanks for submitting!

bottom of page